MENU
+Compare
IMAB
Stock ticker: NASDAQ
AS OF
Oct 29 closing price
Price
$4.63
Change
-$0.01 (-0.22%)
Capitalization
534.83M

IMAB I-MAB Chart, History Price & Graph

a clinical stage biopharmaceutical company, which engages in developing and commercialization of differentiated biologics to treat diseases with significant unmet medical needs, particularly cancers and autoimmune disorders.

IMAB
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
View a ticker or compare two or three
IMAB
Daily Signal:
Gain/Loss:
Interact to see
Advertisement